Results 41 to 50 of about 1,697,740 (179)

Presence and persistence of Ebola or Marburg virus in patients and survivors: A rapid systematic review [PDF]

open access: yes, 2016
Background: The 2013-15 Ebola outbreak was unprecedented due to sustainedtransmission within urban environments and thousands of survivors. In 2014 the World Health Organization stated that there was insufficient evidence to give definitive guidance ...
Brainard, Julii   +4 more
core   +3 more sources

Negative Effect of Smoking on the Performance of the QuantiFERON TB Gold in Tube Test. [PDF]

open access: yes, 2012
False negative and indeterminate Interferon Gamma Release Assay (IGRA) results are a well documented problem. Cigarette smoking is known to increase the risk of tuberculosis (TB) and to impair Interferon-gamma (IFN-γ) responses to antigenic challenge ...
A Cattamanchi   +43 more
core   +1 more source

Isolation of Angola-like Marburg virus from Egyptian rousette bats from West Africa. [PDF]

open access: yes, 2020
Marburg virus (MARV) causes sporadic outbreaks of severe Marburg virus disease (MVD). Most MVD outbreaks originated in East Africa and field studies in East Africa, South Africa, Zambia, and Gabon identified the Egyptian rousette bat (ERB; Rousettus ...
Amara, Emmanuel   +49 more
core  

VP24-Karyopherin alpha binding affinities differ between Ebolavirus species, nfluencing interferon inhibition and VP24 stability [PDF]

open access: yes, 2017
Zaire ebolavirus (EBOV), Bundibugyo ebolavirus (BDBV), and Reston ebolavirus (RESTV) belong to the same genus but exhibit different virulence properties.
Alinger, Joshua B   +6 more
core   +2 more sources

Oral Polio Vaccination and Hospital Admissions With Non-Polio Infections in Denmark:Nationwide Retrospective Cohort Study [PDF]

open access: yes, 2015
Background. Live vaccines may have nonspecific beneficial effects on morbidity and mortality. This study examines whether children who had the live-attenuated oral polio vaccine (OPV) as the most recent vaccine had a different rate of admissions for ...
Aaby, Peter   +5 more
core   +2 more sources

Effect of an Early Dose of Measles Vaccine on Morbidity Between 18 Weeks and 9 Months of Age: A Randomized, Controlled Trial in Guinea-Bissau [PDF]

open access: yes, 2017
BACKGROUND:  Children in Guinea-Bissau receive measles vaccine (MV) at 9 months of age, but studies have shown that an additional dose before 9 months of age might have beneficial nonspecific effects.
Aaby, Peter   +9 more
core   +2 more sources

Measles vaccination in the presence or absence of maternal measles antibody: impact on child survival. [PDF]

open access: yes, 2014
BACKGROUND: Measles vaccine (MV) has a greater effect on child survival when administered in early infancy, when maternal antibody may still be present.
Aaby, Peter   +9 more
core   +1 more source

Superoxide dismutase, catalase, glutathione peroxidase and gluthatione S-transferases M1 and T1 gene polymorphisms in three Brazilian population groups [PDF]

open access: yes, 2011
Antioxidants such as superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX1) reduce the oxidation rates in the organism. Gluthatione S-transferases (GSTs) play a vital role in phase 2 of biotransformation of many substances ...
Guimarães, Maria de Nazaré Klautau   +5 more
core   +3 more sources

Modelling bispecific monoclonal antibody interaction with two cell membrane targets indicates the importance of surface diffusion [PDF]

open access: yes, 2016
We have developed a mathematical framework for describing a bispecific monoclonal antibody interaction with two independent membrane-bound targets that are expressed on the same cell surface.
Argungu, Maryam   +8 more
core   +1 more source

Diagnosis of tuberculosis infection using interferon-γ-based assays [PDF]

open access: yes, 2014
Interferon-γ-based assays, collectively known as IFN-γ release assays (IGRAs), have emerged as a reliable alternative to the old tuberculin skin test (TST) for the immunodiagnosis of tuberculosis (TB) infection.
Aabye   +100 more
core   +2 more sources

Home - About - Disclaimer - Privacy